Non-AIDS-defining hematological malignancies in HIV-infected patients
- 14 January 2013
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 27 (2) , 279-283
Abstract
Objective: To clarify the incidence and clinical outcomes of non-AIDS-defining hematological malignancies (NADHMs), excluding non-Hodgkin's lymphomas, in HIV-infected patients. Design: A nationwide epidemiological study was conducted to evaluate the incidence and clinical outcomes of NADHMs. Methods: Questionnaires were sent to 429 regional AIDS centers and 497 educational hospitals certified by the Japanese Society of Hematology. Data from 511 institutes were obtained. Results: From 1991 to 2010, 47 patients with NADHMs were detected (median age, 42.0 years; male, 93.6%). The median CD4-positive T-cell count was 255/μl, and the median duration from the diagnosis of HIV infection to development of hematological malignancy was 28.0 months. Most patients with acute leukemia were treated with standard induction chemotherapy. Complete remission rates and median overall survival periods for acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) were 70.0 and 85.7% and 13 and 16 months, respectively. Three of four patients with chronic-phase chronic myeloid leukemia (CML-CP) were well controlled with imatinib. Five patients (2 AML, 1 ALL, 1 accelerated-phase CML, and 1 myeloma) were treated with autologous or allogeneic stem-cell transplantation. Comparison of patients over the two periods (1991–2000 and 2001–2009) revealed a 4.5-fold increase in the incidence of hematological malignancies. Conclusion: The incidence of NADHMs has increased in the past decade. The prognosis of these patients was similar to that of HIV-negative patients; therefore, standard chemotherapy may be a feasible treatment option for HIV-infected patients with hematological malignancies.Keywords
This publication has 20 references indexed in Scilit:
- HIV Infection in the Etiology of Lung Cancer: Confounding, Causality, and ConsequencesProceedings of the American Thoracic Society, 2011
- Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral TherapyClinical Infectious Diseases, 2011
- Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials AnalysisOncology, 2011
- A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyAIDS, 2008
- Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDSBlood, 2006
- Human herpesvirus 6 variant A infection with fever, skin rash, and liver dysfunction in a patient after unrelated cord blood transplantationBone Marrow Transplantation, 2005
- Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemiaBone Marrow Transplantation, 2005
- Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasmsOncogene, 2003
- Acute myeloid leukaemia in human immunodeficiency virus‐infected adults: epidemiology, treatment feasibility and outcomeBritish Journal of Haematology, 2001